Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl4) via anti-inflammatory and antioxidant mechanism
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl4) via anti-inflammatory and antioxidant mechanism
Authors
Keywords
-
Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 39, Issue 1, Pages 19-27
Publisher
Informa UK Limited
Online
2016-12-02
DOI
10.1080/08923973.2016.1263860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
- (2016) Shuang Liang et al. Frontiers in Physiology
- Promising Therapy Candidates for Liver Fibrosis
- (2016) Ping Wang et al. Frontiers in Physiology
- Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
- (2016) Fernanda Ferreira Cruz et al. PLoS One
- Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat
- (2016) Huan-Wen Chiu et al. PLoS One
- Mitochondrial Src tyrosine kinase plays a role in the cardioprotective effect of ischemic preconditioning by modulating complex I activity and mitochondrial ROS generation
- (2015) H. Ge et al. FREE RADICAL RESEARCH
- Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice
- (2015) Oznur Yilmaz et al. GROWTH FACTORS
- Protective effects of sesamin on liver fibrosis through antioxidative and anti-inflammatory activities in rats
- (2015) Xiaowei Chen et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Evaluation of anti-asthmatic and antioxidant potential of Boerhavia procumbens in toluene diisocyanate (TDI) treated rats
- (2015) Jasia Bokhari et al. JOURNAL OF ETHNOPHARMACOLOGY
- Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
- (2015) Ting Liu et al. MEDIATORS OF INFLAMMATION
- The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
- (2015) Paloma Almeda-Valdes et al. Biomed Research International
- Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight
- (2014) Gamal E Shiha et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
- (2014) Georgia S. Gaki et al. NEUROMOLECULAR MEDICINE
- The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents
- (2013) C. Dos Santos et al. BLOOD
- Hepatoprotection with a chloroform extract of Launaea procumbens against CCl4-induced injuries in rats
- (2012) Rahmat A Khan et al. BMC Complementary and Alternative Medicine
- TGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
- (2012) Rohan Samarakoon et al. CELLULAR SIGNALLING
- Association between nitric oxide and 8-hydroxydeoxyguanosine levels in semen of diabetic men
- (2012) Iraj Amiri et al. Systems Biology in Reproductive Medicine
- Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes
- (2012) Tao Xue et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis
- (2011) Mohamed E. Shaker et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression
- (2011) Mohamed E. Shaker et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Carbon tetrachloride: A hepatotoxin causes oxidative stress in murine peritoneal macrophage and peripheral blood lymphocyte cells
- (2011) Asis Bala et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib
- (2011) Yuqing Liu et al. JOURNAL OF HEPATOLOGY
- Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
- (2010) Jennifer P. Morton et al. GASTROENTEROLOGY
- Dasatinib inhibits the secretion of TNF-α following TLR stimulation in vitro and in vivo
- (2009) Cara K. Fraser et al. EXPERIMENTAL HEMATOLOGY
- Smad-Independent Transforming Growth Factor-β Regulation of Early Growth Response-1 and Sustained Expression in Fibrosis
- (2008) Swati Bhattacharyya et al. AMERICAN JOURNAL OF PATHOLOGY
- Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis
- (2008) Catherine Skhirtladze et al. ARTHRITIS AND RHEUMATISM
- Novel agents to override imatinib resistance mechanisms
- (2008) Asumi Yokota et al. DRUG DEVELOPMENT RESEARCH
- Identification of the Human Enzymes Involved in the Oxidative Metabolism of Dasatinib: An Effective Approach for Determining Metabolite Formation Kinetics
- (2008) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
- (2008) Alfiya Akhmetshina et al. FASEB JOURNAL
- Ameliorative action of cyanobacterial phycoerythrin on CCl4-induced toxicity in rats
- (2008) Badrish Soni et al. TOXICOLOGY
- Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl
- (2007) Amina El Jamali et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started